Search Results - "Inoue, Masanori"

Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post‐Progression Outcomes: A Multicenter Real‐World Study in Advanced Hepatocellular Carcinoma.

Authors: Inoue, Masanori Ogasawara, Sadahisa Asahara, Kazuhisa et al.

Source: Cancer Medicine. Feb2026, Vol. 15 Issue 2, p1-12. 12p.

Umbilical cord serum metabolomics identifies amino acid alterations associated with impaired linear growth in small for gestational age infants.

Authors: Inoue, Masanori Sekiguchi, Kazuhito Kishimoto, Shintaro et al.

Source: Scientific Reports. 7/28/2025, Vol. 15 Issue 1, p1-11. 11p.

Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate‐Stage Hepatocellular Carcinoma: A Multicenter Cohort Study.

Authors: Taniki, Nobuhito Ojiro, Keisuke Kasuga, Ryosuke et al.

Source: Cancer Medicine. Jan2026, Vol. 15 Issue 1, p1-9. 9p.

Rare Case of Squamous Cell Carcinoma Arising from an Intraosseous Epidermal Cyst: A Diagnostic Challenge.

Authors: Ichikawa, Jiro Onohara, Kojiro Inoue, Tomohiro et al.

Source: Diagnostics (2075-4418). Dec2025, Vol. 15 Issue 24, p3173. 5p.

Biallelic variants in LARS1 induce steatosis in developing zebrafish liver via enhanced autophagy.

Authors: Inoue, Masanori Sebastian, Wulan Apridita Sonoda, Shota et al.

Source: Orphanet Journal of Rare Diseases. 5/28/2024, Vol. 19 Issue 1, p1-14. 14p.

Serotonin Transporter Distribution in the Brainstem of Multiple-System Atrophy–Parkinsonian Type: Insights from Pathology and ¹²³I-FP-CIT SPECT Findings.

Authors: Shang, Cong Nagao, Ryunosuke Riku, Yuichi et al.

Source: Journal of Nuclear Medicine. Apr2026, Vol. 67 Issue 4, p629-635. 7p.

Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage‐associated molecular pattern analysis.

Authors: Ozaki, Tomomi Yumita, Sae Ogasawara, Sadahisa et al.

Source: Hepatology Research. Feb2025, Vol. 55 Issue 2, p291-297. 7p.

Durvalumab Monotherapy in Complex Advanced Hepatocellular Carcinoma: A Real‐World Study of Patients Ineligible for Combination Immunotherapy.

Authors: Miwa, Chihiro Ogasawara, Sadahisa Yonemoto, Takuya et al.

Source: Cancer Medicine. Mar2025, Vol. 14 Issue 5, p1-6. 6p.

Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma.

Authors: Yonemoto, Takuya Ogasawara, Sadahisa Kanogawa, Naoya et al.

Source: Hepatology Research. May2025, Vol. 55 Issue 5, p718-729. 12p.

Advanced image reconstruction algorithms for high-resolution digital time-of-flight PET/CT enhance visualization of sub-clinical internal mammary lymph node metastases in breast cancer: a phantom and a clinical, retrospective cohort study.

Authors: Satoh, Yoko Miwa, Kenta Takenaka, Akinori et al.

Source: EJNMMI Physics. 2/22/2026, Vol. 13 Issue 1, p1-16. 16p.

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma.

Authors: Kanogawa, Naoya Ogasawara, Sadahisa Maruta, Susumu et al.

Source: BMC Gastroenterology. 3/11/2023, Vol. 23 Issue 1, p1-10. 10p.

Billiken as Transcultural Object from American Mascot to Japanese Pop Deity.

Authors: Shores, M. W.¹

Source: Asia Pacific Perspectives; 2025, Vol. 19 Issue 1, p21-63, 43p

Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.

Authors: Kondo, Takayuki Fujimoto, Kentaro Fujiwara, Kisako et al.

Source: Scientific Reports. 11/20/2023, Vol. 13 Issue 1, p1-10. 10p.

Acute myeloid leukemia associated with CHARGE syndrome.

Authors: Shuto, Marie Hirano, Naoki Oguri, Saori et al.

Source: American Journal of Medical Genetics. Part A; Mar2023, Vol. 191 Issue 3, p878-881, 4p

Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice.

Authors: Nakagawa, Miyuki Inoue, Masanori Ogasawara, Sadahisa et al.

Source: Cancer (0008543X). Feb2023, Vol. 129 Issue 4, p590-599. 10p.

Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.

Authors: Kondo, Takayuki Fujiwara, Kisako Nakagawa, Miyuki et al.

Source: Scientific Reports. 7/17/2023, Vol. 13 Issue 1, p1-8. 8p.

Leucyl-tRNA synthetase deficiency systemically induces excessive autophagy in zebrafish.

Authors: Inoue, Masanori Miyahara, Hiroaki Shiraishi, Hiroshi et al.

Source: Scientific Reports. 4/16/2021, Vol. 11 Issue 1, p1-13. 13p.

Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway.

Authors: Hori, Yumiko Hirose, Katsutoshi Aramaki-Hattori, Noriko et al.

Source: Diagnostic Pathology. 7/25/2020, Vol. 15 Issue 1, p1-7. 7p.

Photoluminescence characteristics of Pb-doped, molecular-beam-epitaxy grown ZnSe crystal layers.

Authors: Mita, Yoh Kuronuma, Ryoichi Inoue, Masanori

Source: Journal of Applied Physics; 8/15/2004, Vol. 96 Issue 4, p1904-1908, 5p

Propensity score matching analysis: incidence and risk factors for "stardust" gastric mucosa, a novel gastric finding potentially induced by vonoprazan.

Authors: Yoshizaki, Tetsuya Morisawa, Toshiyuki Fujinami, Maho et al.

Source: Alimentary Pharmacology & Therapeutics. Jan2021, Vol. 53 Issue 1, p94-102. 9p. 2 Color Photographs, 1 Diagram, 5 Charts, 2 Graphs.